Zentrum fuer Gastroenterologie Saar MVZ GmbH
- Address
- lock Available on a paid plan
Zentrum für Gastroenterologie Saar MVZ GmbH
The Zentrum für Gastroenterologie Saar MVZ GmbH is a specialized gastroenterology medical care center dedicated to advancing the treatment and understanding of inflammatory bowel diseases. The center demonstrates particular expertise in conducting sophisticated clinical research for Crohn's Disease, participating in comprehensive multi-phase studies that evaluate novel therapeutic approaches for patients with moderate to severe disease activity.
- Long-term maintenance therapy studies for Crohn's Disease using advanced biologic agents
- Placebo-controlled efficacy and safety evaluations of emerging treatments for inflammatory bowel disease
- Therapeutic drug monitoring and personalized dosing strategies in gastroenterological conditions
The center's research portfolio includes participation in extended clinical trial programs featuring randomized, double-blind protocols as well as open-label long-term extension studies. This involvement in complex study designs, including maintenance therapy evaluation and continuous treatment extensions, reflects the center's commitment to understanding both short-term efficacy and long-term safety profiles of innovative treatments for patients with moderately to severely active Crohn's Disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Zentrum fuer Gastroenterologie Saar MVZ GmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 2 Multicenter Double-Blind Study of Subcutaneous PF-06480605 in Moderate to Severe Active Crohn's Disease | F. Hoffmann-La Roche AG | Phase II | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pf-06480605 | 1 | Unknown | 2023-10-23 | 2023-10-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.